期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

塞来昔布对糖尿病大鼠视网膜组织中Delta样配体4-Notch信号的影响 被引量：1

原文传递
导出
摘要 目前有学者认为糖尿病视网膜病变（DR）是一种炎症性疾病.研究表明,环氧合酶-2（COX-2）在糖尿病（DM）视网膜新生血管的形成过程中发挥了重要的作用,而新生血管形成过程中Notch配体1（notch-1）和血管内皮生长因子（VEGF）是两个重要的调节因子.
作者 艾明 潘桂萍 贺涛 邢怡桥
机构地区 武汉大学人民医院眼科中心
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2010年第2期181-183,共3页 Chinese Journal of Ocular Fundus Diseases
基金 湖北省科技攻关计划项日（302131154）
关键词 糖尿病视网膜病变/病理生理学 塞来昔布/拮抗剂和抑制剂 受体Notchl 糖尿病 实验性
分类号 R774.1 [医药卫生—眼科] R587.26 [医药卫生—内分泌]
  • 相关文献

参考文献10

  • 1Adamis AP.Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol,2002,86:363-365.
  • 2Kim SJ,Flach AJ,Jampol LM.Nonsteroidal Anti-inflammatory Drugs in Ophthalmology.Surv Ophthalmol,2010,55:108-133.
  • 3Williams CK,Li JL,Murga M,et al.Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.Blood,2006,107:931-939.
  • 4付金玲,王桂云.塞来昔布对糖尿病大鼠视网膜血管内皮生长因子表达的影响[J].中华眼底病杂志,2007,23(4):265-268. 被引量：4
  • 5Ayalasomayajula SP,Kompella UB.Celecoxib,a selective cyclooxygenase-2 inhibitor,inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.Eur J Pharmacol,2003,458:283-289.
  • 6Zhang Y,Wang Q,Zhang J,et al.Protection of exendin-4 analogue in early experimental diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol,2009,247:699-706.
  • 7Gale NW,Dominguez MG,Noguera I,et al.Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development.Proc Natl Acad Sci USA,2004,101:15949-15954.
  • 8Sickmann AF,Lawson ND.Notch signaling limits angiogenic cell behaviour in developing zebrafish arteries.Nature,2007,445:781-784.
  • 9Benedito R,Duarte A.Expression of DII4 during mouse embryogenesis suggests multiple developmental roles.Gene Expr Patterns,2005,5:750-755.
  • 10Noguera-Troise I,Daly C,Papadopoulos NJ,et al.Blockade of DII4 inhibits tumour growth by promoting non-productive angiogenesis.Nature,2006,444:1032-1037.

二级参考文献13

  • 1Sone H, Okuda Y, KawakamiY, et al. Effects of high glucose concentration and a thromhoxane synthase inhibitor on the production of thromboxane A2 and prostaglandin I2 and E2 by retinal endothelial cells. Life Sci, 1996, 58: 239-243.
  • 2Cheng T. Cao W. Wen R. et al. Prostaglartdin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest Ophthalmol Vis Sci, 1998, 39:581-591.
  • 3Gonzalez E, Jawerbaum A, Sinner D, et al. Evolution of streptozotocin-pancreatic damage in the rat : modulatory effect of endothelins on the nitridergic and prostanoid pathway. Nitric Oxide, 1999, 3: 459-466.
  • 4Sone H, Okuda Y, Kawakami Y, et al. Effects of high glucose concentration and a thromboxane synthase inhibitor on the production of thromboxane A2 and prostaglandin I2 and E2 by retinal endothelial cells. Life Sci, 1996, 58: 239-243.
  • 5Cheng T, Cao W, Wen R, et al. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest Ophthalmol Vis Sci, 1998, 39:581-591.
  • 6Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes, 2001,50: 1636-1642.
  • 7Johnson EI, Dunlop ME, Larkins RG. Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature. Curr Eye Res, 1999, 18: 79-82.
  • 8Kompella UB, Lee VHL. Barriers to drug transport in ocular epithelia//Amidon GL, Lee PI, Topp EM. Transport Processes in Pharmaceutical Systems. New York: Marcel Dekker, 1999: 317-376.
  • 9Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med, 1994. 331:1480-1487.
  • 10Aukunuru JV, Sunkara G, Ayalasomayajula SP, et al. Evolution of streptozotocin-pancreatic damage in the rat: modulatory effect of endothelins on the nitridergic and prostanoid pathway. Nitric Oxide, 1999, 3:459-466.

共引文献3

同被引文献18

  • 1刘庆淮,谢平,戈应滨,袁孝如.一氧化氮及其合酶在糖尿病视网膜损伤中的作用[J].中华眼科杂志,2005,41(9):837-841. 被引量：18
  • 2Hammes HP, Feng Y, Pfister F, et al. Diabetic retinopathy targeting vasoregression. Diabetes, 2011,60 9-16.
  • 3Asahara T, Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol, 2004, 287~ 572-579.
  • 4Bhatwadekar AD, Glenn JV, Li G, et al. Advanced glycation of fihronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy. Invest Ophthalmol Vis Sci, 2008,49 : 1232-1241.
  • 5Gmez-Cerezo JF, Pagdn-Munoz B, L6pez-Rodriguez M, et al. The role of endothelial progenitor cells and statins in endothelial function: a review. Cardiovasc Hematol Agents Med Chem, 2007,5 : 265-272.
  • 6Navaratna D, McGuire PG, Menicucci G, et al. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes, 2007,56 : 2380-2387.
  • 7Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci,2011,52:1156-1163.
  • 8Ii M. Bone marrow-derived endothelial progenitor ceils: isolation and characterization for myocardial repair. Methods Mol Biol, 2010,660:9-27.
  • 9Hristov M, Erl R, Weber PC mobilization, differentiation, and Vase Biol, 2003,23 : 1185-1189.
  • 10Endothelial progenitor cells homing. Arterioscler Thromb Mishra A, Newman EA. Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy. Glia, 2010,58 : 1996-2004.

引证文献1

二级引证文献2

中华眼底病杂志
2010年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部